Clinical trial
Meloxicam (MOBIC®) Ampoule Post Marketing Surveillance Study
NCT02184052 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Meloxicam (MOBIC®) Ampoule Post Marketing Surveillance Study
- Lead sponsor
- Boehringer Ingelheim
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- Not reported
- Enrollment
- 121 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.